A Phase I, Open-label, Three-Period, Single Sequence, Crossover Study Evaluating the Drug-Drug Interaction Between Eltrombopag and Boceprevir and Between Eltrombopag and Telaprevir in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Eltrombopag (Primary) ; Boceprevir; Telaprevir
- Indications Hepatitis C; Idiopathic thrombocytopenic purpura; Thrombocytopenia
- Focus Pharmacokinetics
- 05 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Aug 2012 New trial record
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.